Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03694431 · ClinicalTrials.gov registry record · NA
Comparative Trial of Home-Based Palliative Care
A NA study, sponsored by Kaiser Permanente.
- Terminated
- Registry status
- NA
- Development phase
- 3,999
- Enrollment target
NCT03694431 is a NA study that was terminated before completion, run by Kaiser Permanente. The registered enrollment target is 3,999 participants.
The verdict
NCT03694431, a NA study, was terminated before completion, sponsored by Kaiser Permanente.
- TERMINATED
- Registry status
- NA
- Development phase
- 3,999 participants
- Enrollment target
Study Summary
Background: To effectively alleviate suffering and improve quality of life for patients with serious illness and their caregivers, palliative care (PC) services must be offered across multiple settings. Research is needed to determine how best to optimize home-based palliative care (HBPC) services to meet the needs of individuals with high symptom burden and functional limitations. Aim: The investigators will compare a standard HBPC model that includes routine home visits by a nurse and provider with a more efficient tech-supported HBPC model that promotes timely inter-professional team coordination via synchronous video consultation with the provider while the nurse is in the patient's home. The investigators hypothesize that tech-supported HBPC will be as effective as standard HBPC. Design: Cluster randomized trial. Registered nurses (n\~130) will be randomly assigned to the tech-supported or standard HBPC model so that half of the patient-caregiver dyads will receive one of the two models. Setting/Participants: Kaiser Permanente (15 Southern California and Oregon sites). Patients (n=10,000) with any serious illness and a prognosis of 1-2 years and their caregivers (n=4,800) Methods: Patients and caregivers will receive standard PC services: comprehensive needs assessment and care planning, pain and symptom management, education/skills training, medication management, emotional/spiritual support; care coordination, referral to other services, and 24/7 phone assistance. Results: Primary patient outcomes: symptom improvement at 1 month and days spent at home in the last six months of life; caregiver outcome: perception of preparedness for caregiving. Conclusion: Should the more efficient tech-supported HBPC model achieves comparable improvements in outcomes that matter most to patients and caregivers, this would have a lasting impact on PC practice and policy.
Interventions
- OTHER Tech-supported HBPC
- OTHER Standard HBPC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,999 participants |
| Start Date | 2019-01-07 |
| Est. Completion | 2020-01-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03694431
The ClinicalTrials.gov registry entry for NCT03694431 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3,999 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tech-supported HBPC is the first listed.
NCT03694431 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03694431 about?
NCT03694431 is a clinical study titled "Comparative Trial of Home-Based Palliative Care". Background: To effectively alleviate suffering and improve quality of life for patients with serious illness and their caregivers, palliative care (PC) services must be offered across multiple settings. Research is needed to determine how best to optimize home-based palliative care (HBPC) services t...
What is the current status of trial NCT03694431?
This trial is currently terminated. It is a NA study. The enrollment target is 3,999 participants. The study started on 2019-01-07. Estimated completion is 2020-01-24.
What interventions are being tested in trial NCT03694431?
The interventions under investigation include: Tech-supported HBPC (OTHER), Standard HBPC (OTHER).
Who is sponsoring clinical trial NCT03694431?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.